$182.63+26.41% · 3M
Moving avg
1W+3.26%
1M+17.92%
3M+27.29%
6M+3.83%
YTD+19.17%
1Y+19.13%
3Y-17.81%
5Y-4.61%
52-week range
$127.5992% of range$187.35
Company health
Value2/6
Growth3/6
Profitability4/6
Health3/6
Dividend3/6
Bull vs bear
Strengths
- High return on equity (379%)
Risks
- Richly valued at 53.7x earnings
Key statistics
Valuation
Market cap
$50.32B
Enterprise value
$65.26B
P/E ratio (TTM)
53.74x
P/S ratio (TTM)
2.36x
EV/EBITDA
16.75x
Per share & returns
EPS (TTM)
$3.42
Dividend yield
2.10%
Beta (1Y)
0.27
30-day change
+17.92%
Trading
Volume (24h)
635.80K
Previous close
$183.58
Shares outstanding
275.54M
About Becton, Dickinson and Company
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NYSE
Symbol
BDX
Becton, Dickinson and Company is a large-cap healthcare company in the Medical - Instruments & Supplies industry. Its shares are listed on NYSE (United States) and trade under the ticker BDX.
Frequently asked questions
What is Becton, Dickinson and Company's market cap?
Becton, Dickinson and Company (BDX) has a market capitalization of $50.32B.
What is Becton, Dickinson and Company's P/E ratio?
Becton, Dickinson and Company trades at a price-to-earnings (P/E) ratio of 53.74.
What exchange does BDX trade on?
BDX trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,217.61-0.22%
$1.15T cap
Johnson & JohnsonJNJ
$261.48+0.24%
$630.14B cap
AbbVie Inc.ABBV
$250.93+0.87%
$443.33B cap
UnitedHealth Group IncorporatedUNH
$402.36-0.80%
$365.40B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.62+1.28%
$332.49B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap